Open AccessWhat to expect and when: benznidazole toxicity in chronic Chagas’ disease treatment
Author(s) -
Edelweiss Aldasoro,
Elizabeth Posada,
Ana RequenaMéndez,
Antonia CalvoCano,
N. Serret,
Aina Casellas,
Sergi Sanz,
Dolors Soy,
MaríaJesús Pinazo,
Joaquím Gascón
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx516
Subject(s) - benznidazole , chagas disease , toxicity , medicine , intensive care medicine , trypanosoma cruzi , immunology , parasite hosting , world wide web , computer science
Benznidazole is one of the two most effective antiparasitic drugs for Chagas' disease treatment. However, knowledge about its toxicity profile is mostly based on post-marketing observational studies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom